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The kinetics of phosphopeptide release from gum fortiﬁed with a commercial casein hydrolysate in
artiﬁcial and human saliva was studied. Using mass spectrometry techniques, the caseinophosphopeptide
(CPP) composition of the commercial casein hydrolysate compared with a standard tryptic casein digest
from whole raw cow milk was determined. In in vitro trials, the amount of CPPs released was always the
same for each chewing time; in contrast, during in vivo chewing, a decrease of peptide levels was
detected, from 10% after 5 min to 0.1% at 20 min, due to physiological swallowing. It is concluded that
gums are a useful vehicle for CPP intake, owing to their functional role in bone health. However, their use
is less satisfactory for prevention of dental caries, due to the brief contact with the enamel surface.
Moreover, more calciumwould need to be added to enrich the CPP fraction of the commercial hydrolysate.
© 2018 Elsevier Ltd. All rights reserved.
1. Introduction
The functional role of caseinophosphopeptides (CPPs) in casein
micelles is to stabilise amorphous calcium phosphate [ACP;
Ca3(PO4)23H2O] at the pH of milk. A decrease in pH destabilises the
micellar structure because of the conversion of ACP into soluble
calcium phosphate salts. CPPs can be generated from casein frac-
tions by proteolytic enzyme action during fermented milk and
cheese production, as well as by gastric protease digestion in vivo.
In this regard, studies carried out on CPPs isolated from ripened
cheeses (Ferranti et al., 1997; Pinto et al., 2010, 2012) and in vivo
digestion (Boutrou et al., 2013; Caira et al., 2016; Cruz-Huerta,
Garcia-Nebot, Miralles, Recio, & Amigo, 2015; Garcia-Nebot, Ale-
gria, Barbera, Contreras,& Recio, 2010; Guilloteau et al., 2009), have
shown the Ser(P)-Ser(P)-Ser(P)-Glu-Glu sequence to be very
resistant to enzymatic degradation by microbial and digestive
proteases, respectively.
This behaviour, exhibited by CPPs only in free form, further at-
tests to the bioactivity of three phosphoryl clusters as carriers of
bivalent cations (Fe, Ca, Mg) in human metabolism (FitzGerald,
1998). The CPP-ACP complex may act at different sites in vivo.
Following ingestion, their ﬁrst site of potential bioactivity is in the
mouth, where they can prevent disease from dental caries and/or
remineralise tooth enamel lesions. CPPs have been found in the
stomach, duodenum and distal ileum of human subjects (Chabance
et al., 1998; Hartmann &Meisel, 2007; Kitasako et al., 2011; Meisel
et al., 2003; Walsh, 2009; Wegehaupt & Attin, 2009).
In the last twenty years, numerous studies have been focused on
the anticariogenic effect of CPP-ACP complex at the tooth surface,
since it can buffer plaque pH, depress enamel demineralisation and
enhance its remineralisation (Reynolds, 1991). An in vitro study by
means of scanning electron microscopy (SEM) analysis showed the
anticariogenic effect of a commercial CPP preparation that was able
to prevent the demineralisation of human enamel dipped in a pH 4.8
lactic solution (Ferrazzano, Cantile, Ingenito, Chianese, & Quarto,
2007). The same authors showed, with the same procedure, the
preventive anticariogenic effect of yoghurt soluble extract
(Ferrazzano et al., 2008). Moreover, among the tryptic CPPs, those* Corresponding author. Tel.: þ39 081 2539011.
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having the three-phosphoryl cluster showedbetterability to stabilise
ACP (Adamson & Reynolds, 1996; Kitts, 2006; Meisel et al., 2003).
Currently, commercially available CPP preparations are obtained
from casein using different pancreatic endoproteinases to release
the clusters of three-phosphorylated pentapeptides (McDonagh &
FitzGerald, 1998). The most prevalent technological process uses
sodium caseinate as raw material and trypsin as the proteolytic
enzyme. The addition of CaCl2 and Na2HPO4, followed by ultraﬁl-
tration, gives rise to casein hydrolysates containing a CPP-ACP
percentage ranging from 6 to 22% (Ellegard, Gammelgard-Larsen,
Sørensen, & Fedosovc, 1999; Reynolds, 2008, 2011).
Notably, the exposure time of teeth to CPP-ACP appears to be a
crucial parameter for the remineralising effect (Nongonierma &
FitzGerald, 2012). To date, CPPs included in vehicles such as
toothpaste, lozenges and chewing gum are available in the nutra-
ceutical market. Chewing gum, in particular, presents the advan-
tage of a longer residence time in the mouth compared with
toothpaste or mouthwash (Cai et al., 2009; Sanares, King,
Itthagarun, & Wong, 2009). However, the remineralising effect of
CPPs, alone or included in a vehicle, has been evaluated in both
in vitro and in situ studies by assessing hydroxyapatite or calcium
ion occlusion into enamel lesions (Ferrazzano et al., 2007;
Reynolds, 1997). For this reason, in the present study, gum forti-
ﬁed with 10% of a commercial casein hydrolysate, previously ana-
lysed for qualitative-quantitative CPP composition, has been
produced and chewedwith artiﬁcial and human saliva. During each
chewing process, salivary samples were collected at different times
and analysed by high performance liquid chromatography (HPLC)
coupled with matrix assisted laser desorption ionisation-time of
ﬂight (MALDI-TOF) mass spectrometry. The objective was to deﬁne
the kinetics of CPP release to evaluate the preventive use of CPPs
against caries disease.
2. Materials and methods
2.1. Samples
Two samples of bovine casein hydrolysate were analysed: a
commercial hydrolysate (CH) product (LACPRODAN DI-2021, pur-
chased from Arla Foods company) and a standard tryptic hydroly-
sate (SH) of bovine isoelectric casein obtained from raw bulk milk
(Aschaffenburg & Drewry, 1959).
2.2. Trypsin enzymatic digestion of casein
The enzyme/substrate ratio was 1:50 (w/w) in 50 mM TriseHCl
buffer, pH 7.8 containing 0.2 M KCl, 4.5 M urea, and 10 mM DTT. The
reaction was carried out at 37 "C for 16 h and stopped by adding
2 mL of 4 M triﬂuoroacetic acid (TFA). The hydrolysate was freeze-
dried and stored at #20 "C before use. The enzymatic digestion
was performed twice.
2.3. Chemical analysis
2.3.1. Determination of CPP content
The CPP content in the commercial hydrolysate (CH) was
assessed by gravimetric analysis (Ferranti et al., 1997). Brieﬂy, 1 mL
10% barium nitrate solution [Ba(NO3)2] and 50/50 water/ethyl
alcohol (30 mL#1) was added to a 10% aqueous solution of CH
sample (5 g per 50mL#1). The suspensionwas centrifuged (4000$g,
10 min), the pellet dissolved in deionised water, acetone was added
(10 mL#1) and pH adjusted to 4.6 with hydrochloric acid. The new
pellet was recovered by centrifugation (4000$g, 10 min), freeze-
dried and weighed. The determination was performed in tripli-
cate, and the powdered sample was stored at #20 "C before use.
2.3.2. Determination of calcium content
Total calcium determination was carried out according a
modiﬁed version of the procedure of Kindstedt and Kosikowski
(1985). Brieﬂy, 3 g of dry ash sample was dissolved in water, then
titrated with ethylenediamine tetra-acetate, as described by
Ntailianas and Whitney (1965).
2.3.3. Determination of the different nitrogen fraction content in
casein hydrolysate
Different nitrogen fractions of CH, i.e., total nitrogen (TN), sol-
uble nitrogen fraction in pH 4.6 acetate buffer (SN), 12% trichloro-
acetic acid (TCA) soluble nitrogen fraction (NPN, non-protein
nitrogen) and degree of hydrolysis (DH, %SN/TN), were prepared
and determined according to the method of IDF (1993), using a
nitrogen protein conversion factor of 6.38.
2.4. In vitro and in vivo chewing study
2.4.1. Chewing gum preparation
Gum preparation, in vivo mastication and in vitro mastication
were carried out following the procedure of Di Stasio, Nazzaro, and
Volpe (2013) as summarised below. The components of the
chewing gum with relative percentages were: gum-base (69%), CH
(10%), ﬂavouring agents and sweeteners (20%), co-adjuvant excip-
ients (talc, magnesium stearate; 1.0%). These were blended in a
laboratory mixer (HulaMixer™ Sample Mixer) and produced by a
single-punch tableting machine (Matrix 2.2 A, Ataena Srl, Ancona,
Italy) at room temperature.
2.4.2. Mechanical chewing
The device for mechanical chewing, well described in Di Stasio
et al. (2013), consisted of a thermostatic cell in which a vertically
oriented piston holding an upper chewing plate wasmounted, with
a second chewing plate on the lower cell surface. The cell, ﬁlled
with 50 mL of artiﬁcial saliva and the chewing gum, was loaded
onto the lower chewing surface. The chewing procedure consisted
of up and down strokes of the upper surface, providing mastication
of the chewing gum. The temperature of the test mediumwas 37 "C
and the chew frequency was 50 ± 2 strokes per min. At pre-
determined time intervals, 500 mL of supernatant was recovered.
The dissolution medium was replaced with fresh artiﬁcial saliva
after each sampling. Three basic tests were carried out, differing
from each other in the chewing duration (5, 10 and 20 min). Each
sample was analysed in triplicate. In each experiment, saliva was
collected, ﬁltered, freeze-dried and stored at #20 "C before use.
2.4.3. Preparation of artiﬁcial saliva
The artiﬁcial saliva consisted of an aqueous solution of 14 mM
sodium chloride, 16.1 mM potassium chloride, 1.7 mM calcium
chloride dihydrate, 0.54 mM magnesium chloride hexahydrate, and
1.49 mM potassium phosphate dibasic, pH 5.7.
2.4.4. Human saliva collection
The in vivo chewing experiment was performed by three vol-
unteers. Each volunteer chewed 1 g of gum for 5, 10 and 20 min. At
each time point, the saliva was collected, lyophilised and stored
at #20 "C before use.
2.5. Reversed-phase high-performance liquid chromatography
analysis
Samples (casein hydrolysate, artiﬁcial and human saliva) were
dissolved in 0.1% TFA at a 2mgmL#1 concentration and loaded onto
a Vydac reversed-phase (RP) C18 column (250 mm, 2.1 mm i.d.).
Samples of 100 mL were injected onto a high-performance liquid
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chromatography (HPLC) system, and peptide mixtures were sepa-
rated by applying a linear gradient from 5 to 60% of solvent B (0.1%
TFA in acetonitrile, v/v) over 60 min at a constant ﬂow rate of
0.2 mL min#1; solvent A was 0.1% TFA in water (v/v). The column
efﬂuent was monitored by UV detection at 220 nm.
2.6. Matrix-assisted laser desorption/ionisation-time-of-ﬂight-mass
spectrometry analysis
Mass spectrometry experiments were carried out by a Voyager
DE-PRO TOF mass spectrometer (PerSeptiveBiosystems, Framing-
ham, MA, USA) equipped with N2 laser (337 nm, 3 ns pulse width).
Dihydroxybenzoic acid was used as a matrix. The sample (1 mL from
a solution inwater) was loaded on the target and dried. Afterwards,
1 mL of a mixture of 10 g L#1 dihydroxybenzoic acid containing 0.1%
phosphoric acid in H2O/acetonitrile (1/1, v/v) was added. For each
sample, mass spectrum acquisition was performed in positive
reﬂector mode accumulating 200 laser pulses. The accelerating
voltage was 20 kV. External mass calibration was performed using
the signal of the matrix dimer together with the monoisotopic
masses of peptide standards, including renin substrate (MW 1761),
bovine b-casein f(33e48) 1P (MW 2061.83) and bovine b-casein
f(1e25) 4P (MW 3122.27) peptides. The mass resolution in the
workingm/z range was >10,000. Post-source decay (PSD) fragment
ion spectra were obtained after isolation of the appropriate peptide
precursor using timed ion selection. Fragment ions were refocused
onto the ﬁnal detector by stepping the ratio of the voltage applied
to the reﬂector to 1.0000 (precursor ion segment), 0.9126, 0.6049,
0.4125, 0.2738 and 0.1975 (fragment ion segments) and recording
data at the digitisation rate of 20 MHz. All precursor ion segments
were acquired at low laser power to avoid saturating the detector;
the laser power was increased for all of the remaining segments of
the PSD acquisitions. Typically, 200 laser shots were acquired for
each fragment ion segment. The individual segments were ﬁnally
combined using the software developed by PerSeptiveBiosystems
for data handling. Raw data were processed using the software
program Data Explorer version 4.0 (Applied Biosystems).
3. Results and discussion
3.1. Chemical analysis
The nutraceutical functionality of casein hydrolysate for remi-
neralisation purposes is strictly dependent on the quantity and
bioavailability of soluble CPPs-ACP complex, which assures, in this
form, calcium transport across the distal small intestine. For this
aim, nitrogen fractions, CPPs and calcium content were assessed
and DH (degree of hydrolysis) was calculated (Table 1). Enzymatic
digestion carried out on the raw material, namely casein or
caseinate, gave rise to a high amount of SN, which allowed the
determination of a 72.2% DH and a 12% TCA-NPN fraction con-
taining oligopeptides, CPPs included, accounting for 38.3% of TN.
Moreover, the calculated percentage of CN indicates that 26.1% of
TN consists of native casein and/or very large peptides while the
remaining percentage (6%) did not contain nitrogen (Table 1).
The low assessed calcium content (0.3%) can be explained by
taking into account the demineralisation of caseins taking place
during the acidiﬁcation of milk carried out in the industrial
preparation.
Furthermore, the content of CPPs represents 17% of the CH
composition. In this regard, a very high CPP/Ca (w/w) ratio (56.6)
was calculated. In studies carried out on the remineralising effects
of CPPs on tooth enamel (Ferrazzano et al., 2007; Reynolds, 1998;
Reynolds, Riley, & Adamson, 1994), this positive effect was
reached using 1% CPP stabilising 60mM CaCl2 at pH 7 corresponding
to a calculated CPP/Ca ratio of 1:2.4. These data suggest the need for
calcium supplementation of such hydrolysates before use.
3.2. Mass spectrometry analysis of standard casein tryptic digest
The technological parameters (pH of hydrolysis, heat treatment)
involved in casein hydrolysate production can result in a loss of
phosphate groups as a consequence of b-elimination reactions
(Calabrese, Mamone, Caira, Ferranti, & Addeo, 2009). For this
reason, a standard tryptic digest of whole casein obtained from raw
whole cow milk was prepared and determined, on analysis with
MALDI-TOF-MS (data not shown), to have an available standard CPP
composition from unheated milk. Among the peptides identiﬁed
(results not shown) thirteen were CPPs, six of which were derived
from aS1-casein (aS1-CN), four from aS2-CN and three from b-CN
(Table 2). In particular, two forms of aS1-CN(f59e79)5P differing
from each other in the modiﬁcation of N-terminal Gln59 to pyro-
glutamic acid (pyroGln) were found, as were two phosphorylated
forms of aS2-CN(f46e70) peptide, differing from each other in one
phosphate (4P and 5P). This occurrence, as reported above, is due to
the different kinase speciﬁcity on Ser or Thr phosphorylation in the
triplet code [Ser/Thr-X-Glu]. As expected on the basis of related
primary structure and the speciﬁcity of action of trypsin, nine of the
identiﬁed CPPs (3 aS1-, 4 aS2- and 2 b-CN) contain the three-
phosphorylated cluster enabling ACP stabilisation in the CPP-ACP
complex (Reynolds, 1998).
3.3. Mass spectrometry analysis of commercial casein hydrolysate
To evaluate the peptide composition of the CH sample, MALDI-
TOF analysis was used, the relative mass spectrum was registered
(Fig. 1) and the peptides were identiﬁed (Table 3). The results show
that this product contains a mixture of eight non-phosphorylated
peptides and ﬁve CPPs, two mono-phosphorylated [aS1-
CN(f104e119)1P, aS2-CN(f22e41)1P], and three containing the
phosphoseryl cluster [aS2-CN(f2e21)4P, b-CN(f1e25)3P, b-
CN(f1e25)4P]. This CPP composition, lacking aS1-CN derived pep-
tides containing the three-phosphorylated pentapeptide clusters,
seems poorer than that of SH (Table 3) as well as that of similar
commercial products (Cross et al., 2007; Reynolds, 2008) having,
among others, the CPP aS1-CN(f59e79)5P. At the same time, it is
known that these peptides have low ionisation power, in particular
of their phosphate group, when analysed inmixturewith other non-
phosphorylated peptides by MALDI-TOF-MS in positive mode
(Mamone, Picariello, Ferranti, & Addeo, 2010). For this reason, an
enriched CPP fraction (EF) from CH hydrolysate was prepared by
addition of barium nitrate Ba(NO3)2, then analysed by MALDI-TOF
analysis (Fig. 1B), and the identiﬁed peptides are reported in Table 3.
Table 1
Protein composition, degree of hydrolysis, calcium and




TN 94.0 ± 2.1
SN 67.9 ± 1.8
NPN 38.3 ± 1.1
CN 26.1 ± 0.9
DH (%, w/w) 72.2
Calcium (%, w/w) 0.30 ± 0.0
CPP (%, w/w) 17.0 ± 0.8
a Abbreviations are: TN, total nitrogen; SN, soluble ni-
trogen; NPN, non-protein nitrogen; CN, casein nitrogen; DH,
degree of hydrolysis (SN/TN); CPP, casein phosphopeptide.
Values are the means of 3 replicates ± standard deviations.
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Table 2
Phosphorylated peptides identiﬁed by MALDI-TOF MS analysis in the standard tryptic casein digest from raw whole cows’ milk.
Peptide Peptide sequence Theoretical molecular mass (Da) Determined molecular mass (m/z) Phosphate residues per mole
aS1-CN(f106e119) VPQLEIVPNSAEER 1659.8 1660.8 1
aS1-CN(f43e58) DIGSESTEDQAMEDIK 1927.7 1927.7 2
b-CN(f33e48) FQSEEQQQTEDELQDK 2060.8 2061.8 1
aS2-CN(f2e21) NTMEHVSSSEESIISQETYK 2619.0 2618.3 4
aS1-CN(f37e58) VNELSKDIGSESTEDQAMEDIK 2678.1 2678.0 3
aS1-CN(f59e79) pyro-QMEAESISSSEEIVPNSVEAQK 2702.9 2703.9 5
aS1-CN(f59e79) QMEAESISSSEEIVPNSVEAQK 2721.1 2720.9 5
aS2-CN(f1e21) KNTMEHVSSSEESIISQETYK 2746.0 2747.0 5
aS1-CN(f35e58) EKVNELSKDIGSESTEDQAMEDIK 2934.2 2935.1 3
aS2-CN(f46e70) NANEEEYSIGSSSEESAEVATEEVK 3007.1 3008.0 4
aS2-CN(f46e70) NANEEEYSIGSSSEESAEVATEEVK 3087.0 3087.9 5
b-CN(f1e25) RELEELNVPGEIVESLSSSEESITR 3042.4 3042.4 3
b-CN(f1e25) RELEELNVPGEIVESLSSSEESITR 3122.4 3123.3 4
Fig. 1. MALDI-TOF mass spectrum of peptides contained in commercial casein hydrolysate (A) compared with its enriched CPP fraction (B).
Table 3
Peptides identiﬁed by MALDI-TOF MS analysis in commercial hydrolysate, its enriched caseinphosphopeptide fraction, in artiﬁcial saliva by mechanically chewing and in
human saliva after in vivo chewing.a
Molecular mass (m/z) Peptide Peptide sequences CH EF MC VC5 VC10 VC20
Theoretical Measured
645.4 645.7 b-CN(f203e209) GPFIIV EF
679.5 679.6 aS1-CN(f101e105) LKKYK VC VC VC
746.5 745.3 aS2-CN(f200e205) VIPYVR MC
748.4 749.3 aS1-CN(f194e199) TTMPLW EF MC VC VC VC
780.5 780.5 b-CN(f170e176) VLPVPQK MC VC VC
830.4 830.5 b-CN(f177e183) AVPYPQR CH MC VC VC VC
903.5 903.4 aS2-CN(f182e188) TVYQHQK MC
1013.5 1013.0 b-CN(f106e113) HKEMPFPK CH MC VC VC
1098.6 1098.6 aS2-CN(f189e197) AMKPWIQPK MC VC VC VC
1267.7 1268.1 aS1-CN(f91e100) YLGYLEQLLR CH EF MC VC VC VC
1337.7 1337.8 aS1-CN(f80e90) HIQKEDVPSER CH EF MC VC VC VC
1384.7 1384.9 aS1-CN(f23e34) FFVAPFPEVFGK EF MC VC VC VC
1386.6 1385.9 aS2-CN(f138e149) TVDMESTEVFTK CH
1633.9 1634.9 aS2-CN(f153e165) LTEEEKNRLNFLK CH MC
1759.9 1760.1 aS1-CN(f8e22) HQGLPQEVLNENLLR CH MC VC VC
1951.9 1952.5 aS1-CN(f104e119)1P YKVPQLEIVPNSAEER CH EF MC
2186.2 2187.0 b-CN(f184e202) DMPIQAFLLYQEPVLGPVR EF MC VC
2235.2 2236.1 aS1-CN(f4e22) HPIKHQGLPQEVLNENLLR CH EF MC VC VC
2363.0 2364.6 aS2-CN(f22e41)1P QEKNMAINPSKENLCSTFK CH MC
2553.2 2553.9 aS2-CN(f138e158)1P TVDMESTEVFTKKTKLTEEEK MC VC
2619.0 2618.3 aS2-CN(f2e21)4P NTMEHVSSSEESIISQETYK CH EF MC VC VC VC
3042.4 3042.4 b-CN(f1e25)3P RELEELNVPGEIVESLSSSEESIT CH EF
3122.4 3123.3 b-CN(f1e25)4P RELEELNVPGEIVESLSSSEESIT CH EF MC VC
Total 13 11 19 15 12 8
a Abbreviations are: CH, commercial hydrolysate; EF, enriched CPP fraction; MC, artiﬁcial saliva by mechanically chewing; VC5, VC10, VC20, human saliva after in vivo
chewing at 5, 10, 20 min, respectively.
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However, the enrichment procedure, even though it intensiﬁed
the signals of the two b-CN(f1e25) phosphorylated peptides,
resulted in a decrease in the aS2-CN(f46e70)4P signal and the loss
of the aS1-CN(f22e41)1P fragment (Fig. 1B). This behaviour shows
that, as in the case of ferric ion (Kibangou et al., 2005), the barium-
binding capacity of CPPs depends on their structural and/or
conformational features. Moreover, the presence of non-
phosphorylated peptides in the EF sample suggested that another
group, such as carboxyl, may also be involved in calcium binding,
enabling an increase in the free calcium content of the hydrolysate
(Meisel, 1998).
3.4. In vitro and in vivo release of CPPs from gum fortiﬁed with 10%
casein hydrolysate
3.4.1. High performance liquid chromatography analysis
To study the kinetics of CPP release in vitro, gum fortiﬁed with
10% CH was mechanically chewed in artiﬁcial saliva (MC) for 5, 10
and 20 min. At the end of each chewing time, the three collected
saliva samples were analysed by RP-HPLC giving rise to three very
similar elution proﬁles, of which a representative one is shown in
Fig. 2A. These preliminary results indicate the inability of the gum
to gradually release peptides, since the release occurred in the ﬁrst
5 min of chewing. From a qualitative point of view, the highest
heterogeneity of peptide composition can be observed in the hy-
drophobic zone of the elution gradient (Fig. 2A).
The RP-HPLC proﬁles of human saliva collected after 5 (VC5), 10
(VC10) and 20 min (VC20) of human gum chewing are shown in
Fig. 2B. Unlike the in vitro counterpart, a quantitative decrease of
extracted peptides during the chewing time was observed in RP-
HPLC proﬁles, obtained by operating at the same full scale value
[Fig. 2B(i)]. In contrast, a very similar peptide composition can be
observed in the hydrophobic zone of the elution gradient, through
the zooming of chromatogram proﬁles [Fig. 2B(ii)]. These quanti-
tative differences, compared with the respective MC results
(Fig. 2A), depend not only on the saliva composition but also on
the characteristics of the reservoir where the mastication occurs.
As reported in the Materials and Methods section, for each
extraction time, both saliva volume and composition remained
unchanged during the mechanical chewing; in the in vivo test,
however, the chewing of gum increased salivation, with conse-
quent dilution of the peptides until their disappearance with
physiological swallowing.
3.4.2. Mass spectrometry analysis
MALDI-TOF-MS analysis carried out on the same samples, ac-
cording to the above HPLC results, gave rise to the representative
mass spectrum shown in Fig. 3A, and the identiﬁed peptides are
reported in Table 3. By comparisonwith the peptide composition of
CH, the highest number of peptides was released in artiﬁcial saliva
(19 versus13), of which ﬁve are CPPs as in the CH sample (Table 3).
In particular, the b-CN(f1e25)3P CPP was not extracted by artiﬁcial
saliva; instead, aS1-CN(f138e158)1P appears.
An additional six peptides, unfound in CH sample and with low
molecular mass, determined the highest heterogeneity of MC in the
low mass range 746.5e1384.7 kDa of MALDI-TOF spectrum.
Moreover, the use of external standard synthetic peptides [b-
CN(f1e25)4P, b-CN(f16e40)1P, aS2-CN(f2e21)4P] in MALDI-TOF
analysis allowed the assessment of an 80% recovery yield of hy-
drolysate components. This decreased recovery rate may depend
on the absorption capacity or afﬁnity of the peptides for the gum.
In agreement with the RP-HPLC results [Fig. 2B(i)], the MALDI-
TOF spectra of human saliva extracts (Fig. 3B) showed a general
decrease in the number and the signal intensity of released pep-
tides as chewing time increased (Table 3). After 5 min chewing, 15
peptides were detected in human saliva of which 14 were common
to the MC counterpart. On the basis of relative signal intensity, a
gradual release of some non-phosphorylated peptides occurs dur-
ing the chewing time, such as the increased aS1-CN(f101e105) and
decreased aS1-CN(f91e100) peptide signals. Regarding the former,
Fig. 2. RP-HPLC proﬁles of peptides released in artiﬁcial saliva by mechanically chewed gum (A), compared with those released in human saliva from chewed gum at 5, 10 and
20 min (B): B(i), chromatographic proﬁles obtained operating at the same full scale value; B(ii) obtained from B(i) by zooming.
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since it has only been found in human saliva, further studies are
needed. In the same way, a gradual selective decrease of CPPs oc-
curs, three [aS2-CN(f138e158)1P, aS2-CN(f2e21)4P and b-
CN(f1e25)4P] after 5 min and just one [aS2-CN(f2e21)4P] after
20 min. These results show a higher afﬁnity for the gum of aS2-
CN(f2e21)4P than b-CN(f1e25)4P having the same number of
phosphate groups. Finally, by using standard synthetic peptides,
the calculated recovery yield of released peptides after 5, 10 and
20 min was calculated as 10, 2 and 0.5%, respectively.
4. Conclusions
Fortiﬁed gum including CPPs extracted from commercial casein
hydrolysate can be a useful medium for CPP release in the oral
cavity during chewing. However a further calcium addition is
aimed at enriching the CPP fraction of commercial hydrolysate
employed in fortiﬁed gum. Finally, an “omic” approach was a
powerful tool for underlining the different CPPs released during
mechanical and in vivo chewing.
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